Celldex Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Celldex Therapeutics stock have an average target of 54.29, with a low estimate of 36 and a high estimate of 80. The average target predicts an increase of 196.83% from the current stock price of 18.29.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$36	$54.29	$46	$80
Change	+96.83%	+196.83%	+151.50%	+337.40%

* Price targets were last updated on Mar 20, 2025.

Analyst Ratings

The average analyst rating for Celldex Therapeutics stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	3	3	3	3	3	3
Buy	2	1	1	1	2	2
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	7	7	7	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Initiates $46	Buy	Initiates	$46	+151.50%	Mar 20, 2025
Richard Law Goldman Sachs	Goldman Sachs	Hold Maintains $42 → $36	Hold	Maintains	$42 → $36	+96.83%	Mar 3, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $80	Strong Buy	Reiterates	$80	+337.40%	Mar 3, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $80	Strong Buy	Reiterates	$80	+337.40%	Feb 28, 2025
Trung Huynh UBS	UBS	Strong Buy Initiates $44	Strong Buy	Initiates	$44	+140.57%	Feb 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.75M

from 7.02M

-46.64%

from 7.02M

Revenue Next Year

3.39M

from 3.75M

-9.40%

from 3.75M

EPS This Year

-3.34

from -2.45

EPS Next Year

-4.01

from -3.34

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	7.42M	4.65M	2.36M	6.88M	7.02M	3.75M	3.39M	41.60M
Revenue Growth	107.61%	-37.30%	-49.32%	192.02%	1.99%	-46.64%	-9.40%	1,125.69%
EPS	-2.02	-1.64	-2.40	-2.92	-2.45	-3.34	-4.01	-3.83
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	13	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	12.6M	12.6M	104.1M
Avg	3.7M	3.4M	41.6M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	79.5%	236.4%	2,968.4%
Avg	-46.6%	-9.4%	1,125.7%
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-2.83	-3.01	-2.88
Avg	-3.34	-4.01	-3.83
Low	-3.60	-5.07	-4.47

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.